These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38100246)

  • 21. Clarithromycin for Helicobacter pylori infection.
    Leung WK; Graham DY
    Expert Opin Pharmacother; 2000 Mar; 1(3):507-14. PubMed ID: 11249534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucus and Biofilm Penetrating Nanoplatform as an Ultrasound-Induced Free Radical Initiator for Targeted Treatment of Helicobacter pylori Infection.
    Fan J; Dong Y; Sun Y; Ji Y; Feng J; Yan P; Zhu Y
    Adv Healthc Mater; 2024 Aug; 13(20):e2400363. PubMed ID: 38558539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori.
    Tehlan A; Karmakar BC; Paul S; Kumar R; Kaur I; Ghosh A; Mukhopadhyay AK; Dhar SK
    FEMS Microbiol Lett; 2020 Nov; 367(21):. PubMed ID: 33118020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug therapy for Helicobacter pylori infection: problems and pitfalls.
    Glupczynski Y; Burette A
    Am J Gastroenterol; 1990 Dec; 85(12):1545-51. PubMed ID: 2174642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbohydrate-Dependent and Antimicrobial Peptide Defence Mechanisms Against Helicobacter pylori Infections.
    Padra M; Benktander J; Robinson K; Lindén SK
    Curr Top Microbiol Immunol; 2019; 421():179-207. PubMed ID: 31123890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori.
    Obonyo M; Zhang L; Thamphiwatana S; Pornpattananangkul D; Fu V; Zhang L
    Mol Pharm; 2012 Sep; 9(9):2677-85. PubMed ID: 22827534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.
    Liu KY; Du FC; Fu Q; Zhang WJ; Sun HW; Zhang Y; Gan le L; Yue ZY; Zou QM; Guo G
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3348-53. PubMed ID: 24687504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pH triggers in situ porous controlled release micro balloon delivery of amoxicillin for eradication of Helicobacter pylori.
    Tripathi GK; Singh S; Nath G; Dubey RK
    Curr Drug Deliv; 2011 Nov; 8(6):667-77. PubMed ID: 22313162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice.
    Henriques PC; Costa LM; Seabra CL; Antunes B; Silva-Carvalho R; Junqueira-Neto S; Maia AF; Oliveira P; Magalhães A; Reis CA; Gartner F; Touati E; Gomes J; Costa P; Martins MCL; Gonçalves IC
    Acta Biomater; 2020 Sep; 114():206-220. PubMed ID: 32622054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
    Makobongo MO; Einck L; Peek RM; Merrell DS
    PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice.
    Yan X; Kita M; Minami M; Yamamoto T; Kuriyama H; Ohno T; Iwakura Y; Imanishi J
    Microbiol Immunol; 2002; 46(7):475-82. PubMed ID: 12222933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pH-Responsive Persistent Luminescence Nanozyme for Selective Imaging and Killing of
    Yan LX; Wang BB; Zhao X; Chen LJ; Yan XP
    ACS Appl Mater Interfaces; 2021 Dec; 13(51):60955-60965. PubMed ID: 34904434
    [No Abstract]   [Full Text] [Related]  

  • 34. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-Decade Failure to the Eradication of Refractory
    Moghadam MT; Chegini Z; Norouzi A; Dousari AS; Shariati A
    Curr Pharm Biotechnol; 2021; 22(7):945-959. PubMed ID: 32767919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard therapeutic regimens in H. pylori infection leads to activation of transitory fungal flora in gastric mucus.
    Khomeriki S
    Eksp Klin Gastroenterol; 2014; (5):16-20. PubMed ID: 25518495
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Chung JW; Kim SY; Park HJ; Chung CS; Lee HW; Lee SM; Kim I; Pak JH; Lee GH; Jeong JY
    Gut Liver; 2017 Sep; 11(5):648-654. PubMed ID: 28750485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.
    Zhang M
    World J Gastroenterol; 2015 Dec; 21(48):13432-7. PubMed ID: 26730153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis.
    Hathroubi S; Servetas SL; Windham I; Merrell DS; Ottemann KM
    Microbiol Mol Biol Rev; 2018 Jun; 82(2):. PubMed ID: 29743338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
    Tseng YY; Liou JM; Hsu TL; Cheng WC; Wu MS; Wong CH
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2412-4. PubMed ID: 24775303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.